 | | Vol. 14.23 – 23 June, 2023 |
| |
|
|
| Researchers showed that androgen deprivation therapy-induced SPP1+ myofibroblastic cancer-associated fibroblasts were critical stromal constituents that drove the development of CRPC.
[Cancer Cell] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors reported that CXCR7 was elevated in the majority of prostate cancer with neuroendocrine features. CXCR7 markedly induced mitotic spindle and cell cycle gene expression.
[Journal of Clinical Investigation] |
|
|
|
| Ipatasertib plus rucaparib was manageable with dose modification but did not demonstrate synergistic or additive antitumor activity in previously treated patients with metastatic CRPC.
[Clinical Cancer Research] |
|
|
|
| Scientists used molecular hybridization of a cationic lipid with a known pharmacophore to produce a bifunctional lipid having a cationic charge to enhance fusion with the cancer cell surface and biological activity.
[Journal of Colloid and Interface Science] |
|
|
|
| The authors revealed that ASCL1 was regulated by the SRY-box transcription factor 2 and highly expressed in neuroendocrine prostate cancer cells, which was closely related to poor prognosis.
[Free Radical Biology and Medicine] |
|
|
|
| Investigators identified ATXN3, a DUB enzyme in the ubiquitin-specific proteases family, as a bona fide deubiquitylase of YAP in prostate cancer.
[Cell Communication and Signaling] |
|
|
|
| Researchers demonstrated that androgen receptor knockdown improved the docetaxel sensitivity of prostate cancer cells by downregulating flap endonuclease 1 (FEN1) through the ERK/ELK1 signaling pathway.
[Cancer Medicine] |
|
|
|
| Scientists investigated the effects of normal fibroblasts and three prostate cancer (PCa) patient-derived fibroblast lines on the expression of cancer-related genes in androgen-sensitive, LNCaP cells, and three sublines showing different androgen sensitivities and androgen receptor dependencies.
[Journal of Cellular Biochemistry] |
|
|
|
| Investigators aimed to assess the in vitro and in vivo targeting efficiency, safety, and efficacy of P563-conjugated, docetaxel-loaded polymeric micelle nanoparticles against prostate cancer.
[Amino Acids] |
|
|
|
| Scientists demonstrated the precision of a panel of miRNAs as biomarkers with diagnostic potential for risk stratification of prostate cancer.
[Prostate International] |
|
|
|
|
| The authors unveil the functional role of a human germline mutation found in the ribonuclease Z enzyme, ELAC2, in prostate cancer.
[Trends In Molecular Medicine] |
|
|
|
|
| Neeraj Agarwal, MD, FASCO, Presidential Endowed Chair of Cancer Research at Huntsman Cancer Institute, received approval from the US FDA for a new prostate cancer treatment.
[University of Utah Health] |
|
|
|
|
| October 4 – 6, 2023
Paris, France |
|
|
|
|
|
| | Cedars Sinai Medical Center – Los Angeles, California, United States |
|
|
|
| | Prostate Cancer UK – London, England, United Kingdom |
|
|
|
| | City of Hope – Duarte, California, United States |
|
|
|
| | University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| | Georgia Cancer Center at Augusta University – Augusta, Georgia, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
